Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders

Psychedelics are a class of hallucinogenic drugs. They have been explored particularly for treatment-resistant psychiatric illnesses. In recent years, advances in psychopharmacology have benefited thousands of patients with some type of mental disorder. Preliminary evidence has shown that psilocybin has shown promise in the treatment of psychiatric disorders, with the support of qualified doctors. Recent clinical studies have reported marked improvements in mental health in psilocybinassisted psychotherapy. In many studies, the safety and efficacy of psilocybin have been the primary objectives to show that it is a safe and valid therapeutic alternative to other forms of psychiatric medications. Currently, some studies prove that psilocybin is safe in a controlled environment. However, the use of psilocybin needs to be further studied to determine the efficacy and safety of potential applications in medicine.

Open source BibTeX RIS

Bibliographic context

Journal
Annals of Bioethics & Clinical Applications
Date
2023-12-31
Source
OpenAlex
DOI
10.23880/abca-16000266
PubMed
Unavailable

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Related papers